Silo pharma to discuss mainstream pharma and psychedelics at wonderland miami conference

Englewood cliffs, nj, oct. 26, 2022 (globe newswire) -- silo pharma, inc. (nasdaq: silo) (“the company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that james kuo, m.d. m.b.a, vice president of r&d, will speak as a panelist at wonderland: miami, the largest business gathering in the psychedelic medicine sector. silo pharma is a sponsor of the three-day conference being held november 3-5, 2022, in miami, florida.
SILO Ratings Summary
SILO Quant Ranking